Health Network Laboratories, LLC

Health Network Laboratories, LLC was paid $47.53M by Medicaid between Jan 2018 and Dec 2024, across 310 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 19% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Pennsylvania

Rank by total paid#5 of 95

Median peer was paid$153K

This provider vs. median311×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	30,265	$328K
2019	30,601	$334K
2020	113,065	$2.83M
2021	518,273	$12.95M
2022	501,683	$11.76M
2023	526,286	$10.49M
2024incomplete	447,221	$8.85M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	19%	117,164	108,794	$9.10M
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	4.7%	21,178	20,728	$2.24M
80050	General health panel	4.1%	47,633	46,689	$1.96M
87631		3.8%	13,397	13,065	$1.82M
88305	Level IV - Surgical pathology, gross and microscopic examination	3.6%	46,272	35,714	$1.73M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	3.6%	71,885	70,308	$1.73M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	3.4%	28,503	25,228	$1.60M
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	3.2%	2,634	2,574	$1.54M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	3.1%	64,822	63,325	$1.49M
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	2.9%	41,572	40,292	$1.36M
80061	Lipid panel	2.6%	98,992	97,088	$1.26M
80053	Comprehensive metabolic panel	2.5%	119,596	111,655	$1.19M

298 more codes

88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	2.3%	37,025	$1.07M
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	2.2%	19,066	$1.06M
84443	Thyroid stimulating hormone (TSH)	1.9%	47,584	$898K
87800		1.7%	36,373	$799K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	1.7%	21,696	$790K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	1.3%	24,524	$638K
86480		1.2%	8,712	$565K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.1%	102,803	$532K
88342		1.1%	12,286	$504K
88307		1.0%	12,122	$482K
86803		1.0%	27,027	$481K
86780		<1%	27,995	$394K
87086	Culture, bacterial; quantitative colony count, urine	<1%	53,513	$391K
80081		<1%	4,728	$361K
83036	Hemoglobin; glycosylated (A1C)	<1%	57,411	$348K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	10,073	$343K
87653		<1%	8,601	$323K
82728		<1%	26,536	$290K
86003		<1%	3,004	$271K
84466		<1%	17,058	$255K
87536		<1%	2,465	$250K
80048	Basic metabolic panel (calcium, ionized)	<1%	31,521	$230K
85027		<1%	34,234	$212K
86706		<1%	17,266	$205K
87522	Neg quan hep c or qual rna	<1%	5,959	$201K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	595	$201K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	6,201	$201K
86235		<1%	4,800	$199K
82607		<1%	17,223	$188K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	30,717	$184K
80074		<1%	4,287	$176K
88341		<1%	3,787	$172K
83970		<1%	4,776	$171K
84702		<1%	11,234	$171K
86618		<1%	5,483	$167K
84403		<1%	6,484	$163K
84439		<1%	21,031	$147K
87340		<1%	10,972	$147K
82570		<1%	23,270	$143K
83540		<1%	19,367	$143K
88112		<1%	2,953	$140K
88360		<1%	2,025	$135K
84153		<1%	5,948	$126K
82043		<1%	18,356	$125K
86038		<1%	8,167	$114K
87186		<1%	15,654	$112K
87077		<1%	16,279	$107K
82784		<1%	6,840	$107K
83655		<1%	10,374	$106K
87507		<1%	839	$105K
84146		<1%	4,596	$103K
88304		<1%	8,866	$99K
G0476	Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test	<1%	2,664	$99K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	213	$95K
86704		<1%	6,858	$95K
83735		<1%	16,067	$91K
81001		<1%	34,618	$91K
86708		<1%	6,591	$89K
86360		<1%	1,489	$85K
86696		<1%	3,852	$85K
83001		<1%	5,016	$82K
84270		<1%	3,334	$80K
85610		<1%	23,354	$77K
88189		<1%	1,106	$76K
82670		<1%	3,766	$76K
86225		<1%	4,911	$67K
86160		<1%	3,152	$67K
86359		<1%	1,492	$67K
88312		<1%	1,439	$66K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	371	$62K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	1,617	$60K
88313		<1%	2,143	$60K
86695		<1%	3,098	$59K
84481		<1%	2,844	$58K
36415	Collection of venous blood by venipuncture	<1%	97,991	$58K
82746		<1%	6,104	$58K
83525		<1%	5,352	$56K
86665		<1%	1,696	$56K
86200		<1%	4,076	$55K
83002		<1%	3,397	$54K
85652		<1%	19,654	$54K
86140		<1%	19,122	$54K
82105		<1%	2,946	$53K
81329		<1%	593	$53K
81514		<1%	761	$52K
88141		<1%	7,658	$51K
84165		<1%	4,392	$51K
81003		<1%	17,937	$49K
80164		<1%	3,434	$48K
83880		<1%	1,789	$47K
87634		<1%	673	$44K
86147		<1%	779	$44K
G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	<1%	2,181	$43K
87081		<1%	8,341	$43K
86039		<1%	2,950	$41K
86617		<1%	1,412	$40K
86800		<1%	2,392	$40K
86431		<1%	5,506	$39K
82950		<1%	5,959	$38K
86762		<1%	2,057	$37K
80076		<1%	4,537	$37K
87070		<1%	5,572	$35K
82627		<1%	1,682	$34K
81374		<1%	522	$34K
86850		<1%	4,186	$33K
86664		<1%	1,640	$31K
88311		<1%	2,278	$31K
83021		<1%	1,600	$30K
82977		<1%	3,897	$29K
84100		<1%	5,682	$29K
84156		<1%	7,727	$29K
86663		<1%	1,647	$27K
86787		<1%	1,622	$27K
84550		<1%	4,992	$26K
87209		<1%	1,341	$26K
82248		<1%	5,143	$26K
86146		<1%	588	$26K
82533		<1%	2,254	$26K
83498		<1%	1,244	$25K
88173		<1%	754	$23K
84460		<1%	3,548	$23K
88142		<1%	1,440	$23K
86376		<1%	2,999	$23K
88302		<1%	2,451	$23K
84630		<1%	1,795	$22K
87529		<1%	1,003	$22K
82550		<1%	3,481	$22K
84480		<1%	2,994	$22K
87205		<1%	5,254	$21K
82951		<1%	1,697	$21K
80197		<1%	1,902	$20K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	2,275	$20K
84590		<1%	1,545	$19K
86705		<1%	1,238	$19K
84436		<1%	2,561	$18K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	398	$18K
82024		<1%	468	$17K
83993		<1%	850	$17K
86900		<1%	4,460	$17K
86901		<1%	4,367	$17K
85730		<1%	2,778	$17K
86318		<1%	1,005	$17K
84144		<1%	1,149	$17K
87902		<1%	187	$16K
88309		<1%	359	$16K
84425		<1%	2,250	$16K
84305		<1%	653	$15K
87075		<1%	1,637	$15K
80069		<1%	1,983	$15K
87088		<1%	1,995	$15K
87147		<1%	4,265	$14K
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	21,893	$14K
87517		<1%	399	$14K
84432		<1%	664	$14K
84445		<1%	675	$14K
86364		<1%	2,689	$13K
83921		<1%	813	$13K
84166		<1%	825	$13K
84207		<1%	395	$13K
87493		<1%	375	$13K
83690		<1%	2,761	$13K
84154		<1%	766	$13K
82247		<1%	1,893	$12K
86765		<1%	1,092	$12K
80178		<1%	1,856	$12K
87486		<1%	325	$12K
82785		<1%	721	$12K
82565		<1%	2,099	$11K
80177		<1%	978	$11K
83615		<1%	1,815	$11K
82274		<1%	3,507	$11K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	115	$10K
84402		<1%	404	$10K
87177		<1%	1,339	$10K
84134		<1%	533	$9K
82378		<1%	624	$9K
83721		<1%	1,011	$9K
85007		<1%	2,124	$9K
87581		<1%	477	$8K
86255		<1%	363	$8K
82947		<1%	2,241	$8K
85045		<1%	1,843	$8K
86769		<1%	452	$7K
86008		<1%	109	$7K
85379		<1%	765	$7K
85613		<1%	579	$6K
82575		<1%	609	$6K
88331		<1%	252	$6K
84450		<1%	925	$6K
82330		<1%	708	$6K
87338		<1%	951	$6K
82652		<1%	128	$5K
82525		<1%	473	$5K
86334		<1%	282	$5K
84681		<1%	201	$5K
86592		<1%	1,393	$5K
86036		<1%	485	$5K
88300		<1%	1,268	$5K
83516		<1%	656	$5K
82952		<1%	1,412	$5K
82150		<1%	1,011	$4K
81596		<1%	98	$4K
83521		<1%	239	$4K
85018		<1%	1,723	$4K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	275	$4K
81015		<1%	1,546	$4K
88333		<1%	92	$4K
86645		<1%	177	$4K
83520		<1%	427	$4K
86709		<1%	260	$4K
82088		<1%	142	$3K
82164		<1%	181	$3K
87563		<1%	122	$3K
86644		<1%	182	$3K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	36	$3K
84155		<1%	775	$3K
82310		<1%	520	$3K
86812		<1%	243	$3K
80175		<1%	228	$3K
87481		<1%	103	$3K
80156		<1%	163	$3K
85245		<1%	84	$2K
86304		<1%	131	$2K
89051		<1%	376	$2K
85014		<1%	1,056	$2K
82140		<1%	504	$2K
87102		<1%	252	$2K
87101		<1%	220	$2K
86015		<1%	232	$2K
82085		<1%	232	$2K
82390		<1%	209	$2K
86308		<1%	277	$2K
86735		<1%	432	$2K
84244		<1%	139	$2K
84478		<1%	248	$2K
82672		<1%	110	$1K
86300		<1%	61	$1K
83835		<1%	108	$1K
83010		<1%	118	$1K
84520		<1%	272	$1K
86317		<1%	20	$1K
82103		<1%	77	$1K
81511		<1%	12	$1K
85246		<1%	38	$1K
82955		<1%	127	$1K
82239		<1%	68	$991.08
88344		<1%	16	$991.08
82157		<1%	39	$974.93
81025		<1%	240	$960.70
88377		<1%	18	$938.77
87220		<1%	241	$924.69
87641		<1%	31	$853.51
86593		<1%	127	$708.26
86341		<1%	26	$689.31
87497		<1%	24	$676.80
84132		<1%	118	$638.98
85097		<1%	40	$632.88
81241		<1%	12	$596.97
87521	Neg quan hep c or qual rna	<1%	14	$550.22
85240		<1%	44	$537.86
86381		<1%	69	$527.47
81050		<1%	408	$503.93
86141		<1%	52	$502.10
82653		<1%	27	$476.34
86256		<1%	55	$456.09
82787		<1%	13	$415.92
84484		<1%	47	$390.90
87110		<1%	16	$378.14
89060		<1%	52	$320.66
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	156	$315.54
82040		<1%	113	$310.71
87329		<1%	24	$290.92
87045		<1%	38	$254.91
86231		<1%	28	$243.57
87076		<1%	25	$195.72
84145		<1%	26	$183.10
85660		<1%	59	$179.03
82340		<1%	25	$175.70
86611		<1%	12	$159.09
87040		<1%	14	$145.38
87107		<1%	12	$142.17
82397		<1%	27	$128.35
86666		<1%	12	$119.71
87449		<1%	29	$110.29
87324		<1%	28	$110.29
83605		<1%	15	$100.32
G0471	Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)	<1%	3,894	$98.67
82945		<1%	27	$93.44
86060		<1%	13	$84.16
84300		<1%	14	$80.30
82465		<1%	14	$79.63
85004		<1%	15	$61.12
89055		<1%	13	$54.00
84075		<1%	12	$53.07
82438		<1%	15	$48.90
87140		<1%	16	$45.62
86682		<1%	38	$8.46
36416		<1%	346	$3.41

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTILL, MARTIN (PRESIDENT & CEO)